Inventor · disambiguated record
Michael L. Dustin
Also filed as: DUSTIN MICHAEL · DUSTIN MICHAEL L · DUSTIN MICHAEL LORAN · STAUNTON DONALD E
14 granted patents·8 pending applications·449 citations·filing 1987–2024
94Inventor score
Files withDANA FARBER CANCER INST INC12UNIV MINNESOTA3BIOGEN INC1BOEHRINGER INGELHEIM PHARMA1BROWN MARYANNE1
Top patents by PatentIndex Score
22 records- 0193US5284931AIntercellular adhesion molecules, and their binding ligandsDANA FARBER CANCER INST INC·Filed 1990·Granted Feb 8, 1994·95 cites·11 claims
- 0290US4956281ADNA sequences, recombinant DNA molecules and processes for producing lymphocyte function associated antigen-3BIOGEN INC·Filed 1987·Granted Sep 11, 1990·108 cites·10 claims
- 0385US5475091AR6-5-D6, an antibody which binds intercellular adhesion molecule-1DANA FARBER CANCER INST INC·Filed 1994·Granted Dec 12, 1995·45 cites·2 claims
- 0481US5071964AProtein micellesDANA FARBER CANCER INST INC·Filed 1990·Granted Dec 10, 1991·53 cites·6 claims
- 0571US5612216ANucleotide sequence encoding intercellular adhesion molecule-1 and fragments thereofDANA FARBER CANCER INST INC·Filed 1994·Granted Mar 18, 1997·23 cites·10 claims
- 0668US2025281534A1Methods and compositions for improving immunotherapyUNIV MINNESOTA·Filed 2024·Application pending·0 cites
- 0767US5831036ASoluble fragments of human intercellular adhesion molecule-1DANA FARBER CANCER INST INC·Filed 1993·Granted Nov 3, 1998·22 cites·4 claims
- 0861US5565550AAntibodies to ICAM-2, and fragments thereofDANA FARBER CANCER INST INC·Filed 1994·Granted Oct 15, 1996·21 cites·4 claims
- 0961US5489533AIsolated nucleic acid molecules encoding ICAM-2DANA FARBER CANCER INST INC·Filed 1995·Granted Feb 6, 1996·23 cites·4 claims
- 1059US6358510B1ICAM-1 derivatives with altered ability to bind LFA-1DANA FARBER CANCER INST INC·Filed 1995·Granted Mar 19, 2002·15 cites·4 claims
- 1159US5190859APurification of LFA-3DANA FARBER CANCER INST INC·Filed 1989·Granted Mar 2, 1993·18 cites·12 claims
- 1259US2024239847A1Proteinaceous particleUNIV OXFORD INNOVATION LTD·Filed 2021·Application pending·0 cites
- 1354US2021322455A1Methods and compositions for increasing the suppressive function of regulatory t-cells (tregs)UNIV MINNESOTA·Filed 2021·Application pending·0 cites
- 1454US2009035321A1Intercellular adhesion molecules and their binding ligandsBOEHRINGER INGELHEIM PHARMA·Filed 2006·Application pending·0 cites
- 1553US10993959B2Methods and compositions for increasing the suppressive function of regulatory T-cells (Tregs)UNIV MINNESOTA·Filed 2016·Granted May 4, 2021·0 cites·16 claims
- 1652US6511664B1Intercellular adhesion molecule—2 and its binding ligandsDANA FARBER CANCER INST INC·Filed 1996·Granted Jan 28, 2003·12 cites·4 claims
- 1751US5512660APurified ICAM-2 and fragment thereofDANA FARBER CANCER INST INC·Filed 1994·Granted Apr 30, 1996·14 cites·2 claims
- 1842US2014350078A1Controlling regulatory t cell functionDUSTIN MICHAEL·Filed 2012·Application pending·0 cites
- 1939US2011142814A1Methods for Using Protein Kinase C-Theta Inhibitors in Adoptive ImmunotherapyUNIV NEW YORK·Filed 2010·Application pending·0 cites
- 2039US2008317724A1Micropatterned T cell stimulationKAM LANCE·Filed 2008·Application pending·0 cites
- 2134US2012196919A1Ex-vivo treatment of immunological disorders with pkc-theta inhibitorsBROWN MARYANNE·Filed 2010·Application pending·0 cites
- 2230US7354588B1Functional derivatives of ICAM-1 with altered ability to bind LFA-1 or HRVDANA FARBER CANCER INST INC·Filed 1995·Granted Apr 8, 2008·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Michael L. Dustin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →